EC 7072
Alternative Names: EC-7072; Mithramycin analog - EntreChemLatest Information Update: 19 Feb 2023
At a glance
- Originator EntreChem
- Class Anthracyclines; Antineoplastics; Cytostatic antibiotics
- Mechanism of Action Sp1 transcription factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Chronic lymphocytic leukaemia
Most Recent Events
- 25 Jan 2023 Discontinued - Preclinical for Chronic lymphocytic leukaemia in Spain (unspecified route)
- 23 Jan 2023 Preclinical trials in Chronic lymphocytic leukaemia in Spain (unspecified route) prior to January 2023 (EntreChem pipeline, January 2023)
- 18 Oct 2019 Adverse events and pharmacodynamics data from preclinical studies in Chronic lymphocytic leukaemia released by Entrechem